|
|
|
Volumn 17, Issue 7 Suppl 7, 2003, Pages 27-29
|
|
Irinotecan and carboplatin in metastatic or recurrent non-small-cell lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CARBOPLATIN;
DRUG DERIVATIVE;
IRINOTECAN;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
SURVIVAL;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0142122113
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
